BRPI0412843A - lactamas substituìdas e uso das mesmas como agentes anticáncer - Google Patents

lactamas substituìdas e uso das mesmas como agentes anticáncer

Info

Publication number
BRPI0412843A
BRPI0412843A BRPI0412843-5A BRPI0412843A BRPI0412843A BR PI0412843 A BRPI0412843 A BR PI0412843A BR PI0412843 A BRPI0412843 A BR PI0412843A BR PI0412843 A BRPI0412843 A BR PI0412843A
Authority
BR
Brazil
Prior art keywords
anticancer agents
substituted lactams
lactams
compounds
substituted
Prior art date
Application number
BRPI0412843-5A
Other languages
English (en)
Inventor
Kenneth Walter Bair
Frederick Ray Kinder Jr
Richard William Versace
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0412843A publication Critical patent/BRPI0412843A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"LACTAMAS SUBSTITUìDAS E USO DAS MESMAS COMO AGENTES ANTICáNCER". A presente invenção refere-se a determinados compostos de lactama substituídos da fórmula (I), especificamente compostos de caprolactama, que são úteis para o tratamento de câncer.
BRPI0412843-5A 2003-07-25 2004-07-23 lactamas substituìdas e uso das mesmas como agentes anticáncer BRPI0412843A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49041503P 2003-07-25 2003-07-25
PCT/EP2004/008284 WO2005014574A1 (en) 2003-07-25 2004-07-23 Substituted lactams and their use as anti-cancer agents

Publications (1)

Publication Number Publication Date
BRPI0412843A true BRPI0412843A (pt) 2006-09-26

Family

ID=34135104

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412843-5A BRPI0412843A (pt) 2003-07-25 2004-07-23 lactamas substituìdas e uso das mesmas como agentes anticáncer

Country Status (9)

Country Link
US (2) US7378410B2 (pt)
EP (1) EP1651633A1 (pt)
JP (1) JP2006528611A (pt)
CN (1) CN1856486A (pt)
AU (1) AU2004263287B2 (pt)
BR (1) BRPI0412843A (pt)
CA (1) CA2533335A1 (pt)
MX (1) MXPA06000975A (pt)
WO (1) WO2005014574A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) * 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
CN101092384A (zh) * 2006-06-22 2007-12-26 中国科学院上海药物研究所 一类α－氨基－N－取代酰胺化合物、其组合物及用途
US7968708B2 (en) 2006-12-06 2011-06-28 The Research Foundation Of State University Of New York Azepans and methods for making and using same
GB2451451A (en) * 2007-07-30 2009-02-04 Inion Ltd Osteogenic compounds
CN101456824B (zh) 2007-12-11 2013-04-17 中国科学院上海药物研究所 α-氨基-N-取代酰胺化合物、包含该化合物的药物组合物及其用途
DK2231590T3 (da) * 2007-12-20 2012-07-09 Pharma Mar Sa Antitumorforbindelser
WO2013036861A1 (en) 2011-09-08 2013-03-14 Codexis, Inc Biocatalysts and methods for the synthesis of substituted lactams
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831135A (en) * 1986-06-18 1989-05-16 The Regents Of The University Of California Bengamide anthelmintics
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
ATE383341T1 (de) 2000-05-11 2008-01-15 Novartis Pharma Gmbh Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe
EP1337854A2 (en) 2000-11-14 2003-08-27 Novartis AG Method for screening anti-proliferative compounds and inhibiting tumor growth

Also Published As

Publication number Publication date
US7378410B2 (en) 2008-05-27
AU2004263287B2 (en) 2009-02-12
WO2005014574A1 (en) 2005-02-17
AU2004263287A1 (en) 2005-02-17
MXPA06000975A (es) 2006-04-11
JP2006528611A (ja) 2006-12-21
CN1856486A (zh) 2006-11-01
EP1651633A1 (en) 2006-05-03
US20080275025A1 (en) 2008-11-06
US20060281731A1 (en) 2006-12-14
CA2533335A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
ATE433447T1 (de) Pyrimiidinverbindungen
UY28186A1 (es) N-arilheterociclos sustituidos, procedimientos para su preparación, y su empleo como medicamentos.
ECSP066391A (es) [1,8] naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
GB0130341D0 (en) Compounds
BRPI0412843A (pt) lactamas substituìdas e uso das mesmas como agentes anticáncer
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
AR028948A1 (es) Compuestos novedosos
ECSP045139A (es) DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5
SE0301700D0 (sv) Novel compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
TW200738659A (en) Novel compounds
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
ES2243579T3 (es) Derivados de pirazolopirideno.
ZA200604410B (en) Imidazole derivatives, processes for preparing them and their uses
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
SE0302139D0 (sv) Novel compounds
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
SE9901077D0 (sv) Novel use
ATE368040T1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren
BRPI0413820A (pt) derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
ES2152648T3 (es) Difenilestilbenos como profarmacos inhibidores de la cox-2.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2143 DE 31/01/2012.